Kyntra Bio (KYNB) Liabilities from Discontinued Operations (2023 - 2025)

Kyntra Bio has reported Liabilities from Discontinued Operations for 3 years, with the latest figure at 8458000.0 in Q2 2025.

• Quarterly Liabilities from Discontinued Operations changed N/A year-over-year to 8458000.0 in Q2 2025, while the trailing twelve-month figure through Jun 2025 was 8458000.0 (changed N/A YoY) and the FY2024 annual result came in at 356000.0, down 99.18% from the prior year.
• Liabilities from Discontinued Operations climbed to 8458000.0 in Q2 2025 per KYNB's latest filing, from 189000.0 in the prior quarter.
• Over five years, Liabilities from Discontinued Operations peaked at 43516000.0 in Q4 2023 and troughed at 189000.0 in Q1 2025.
• A 3-year average of 13129750.0 and a median of 4407000.0 in 2024 frame the typical range for Liabilities from Discontinued Operations.
• The widest YoY moves for Liabilities from Discontinued Operations: up 99.18% in 2024, down 99.18% in 2024.
• Over 3 years, Liabilities from Discontinued Operations stood at 43516000.0 in 2023, then plunged by 99.18% to 356000.0 in 2024, then soared by 2275.84% to 8458000.0 in 2025.
• According to Business Quant data, Liabilities from Discontinued Operations over the past three periods registered 8458000.0, 189000.0, and 356000.0 for Q2 2025, Q1 2025, and Q4 2024 respectively.